Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Emerging Microbes & Infections|September 2, 2024
Novel recombinant vaccinia virus-vectored vaccine affords complete protection against homologous Borrelia burgdorferi infection in miceAnnabelle Pfeifle, Wanyue Zhang, Jingxin Cao, et al.
Nature Communications|November 2, 2021
A Slam-dependent hemophore contributes to heme acquisition in the bacterial pathogen Acinetobacter baumanniiThomas J Bateman, Megha Shah, Timothy Pham Ho, et al.
Vaccine|August 7, 2019
Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunizationFelicity C Stark, Bassel Akache, Amalia Ponce, et al.
Pathogens (Basel, Switzerland)|May 7, 2025
Borrelia burgdorferi Strain-Specific Differences in Mouse Infectivity and PathologyAnnabelle Pfeifle, Rose Anderson-Duvall, Levi A Tamming, et al.
Frontiers in Immunology|April 16, 2019
Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral VaccineMarsha S Russell, Marybeth Creskey, Abenaya Muralidharan, et al.
Emerging Microbes & Infections|November 7, 2024
Dissecting immunological mechanisms underlying influenza viral nucleoprotein-induced mucosal immunity against diverse viral strainsWanyue Zhang, Angela Sloan, Jérémie Prévost, et al.
Iscience|November 22, 2021
Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineagesCaroline Gravel, Abenaya Muralidharan, Amparo Duran, et al.
NPJ Vaccines|January 31, 2026
Durability of DNA-LNP and mRNA-LNP vaccine-induced immunity against sars-cov-2 xbb.1.5Levi Tamming, Casey Lansdell, Wanyue Zhang, et al.
Antiviral Research|September 27, 2025
Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A virusesWanyue Zhang, Jérémie Prévost, Angela Sloan, et al.
Scientific Reports|November 9, 2021
Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvantBassel Akache, Tyler M Renner, Anh Tran, et al.
Pageof 14